Concluding, DPP-4i have mixed results regarding the mortality in T2DM patients with COVID-19 and overall seems to have a slightly favourable or neutral effect, whereas GLP-1 Ra seems to have a rather beneficial impact. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.